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Letters to the Editor
High-protein diet, obesity, and the environment
Dear Sir:
Weigle et al (1) raise the intriguing question of whether high-
protein diets are useful in preventing and treating excess body fat—a
clinical issue that affects more than one billion people. They showed
that a high protein intake reduces body weight by increasing satiety.
Their study, together with the editorial by Astrup (2), raises the
question of whether high-protein diets should be promoted in large
numbers of people, particularly given the high protein intake typical
of Western diets. Suffice it to note that the current estimated protein
intake in the United States is already more than double the recom-
mended amount (3). As a matter of fact, the human species is om-
nivorous and has developed very efficient adaptive physiologic
mechanisms for fuel utilization, notwithstanding the feast or famine
pendulum and that meat constituted the staple diet of our pre-
Neolithic ancestors (4).
However, a meat-based diet—which has a high protein con-
tent—is largely less environmentally sustainable than is a
vegetarian-based diet nowadays (5). A meat-based diet had little
effect when the world’s population numbered only a few million,
unlike today when more than 6 billion individuals are competing for
resources. Furthermore, a high-protein diet may have untoward ef-
fects, for example, on calcium and bone metabolism (6, 7).
In conclusion, the findings reported by Weigle et al confirm some
basic physiologic concepts of human nutrition; a high-protein diet
can have untoward effects, may be difficult to adhere to, and, most
importantly, is not environmentally sustainable. Thus, caution
should be exercised in applying the findings of Weigle et al in the
clinical setting.
Neither author had a conflict of interest.
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Reply to F Contaldo and F Pasanisi
Dear Sir:
Contaldo and Pasinisi raise important questions about whether
increases in the protein content of the diet should be recommended
for the prevention and treatment of obesity. In my editorial I mainly
addressed the potential health benefits of increasing the proportion
of dietary energy provided by protein at the expense of a reduction
in fat and carbohydrate sources that are less satiating. I can only agree
that many other issues need to be taken into account, such as safety
aspects, economy, and environmental issues, before such recom-
mendations should be made.
In no way do I wish to suggest that overweight and obesity are
“protein-deficiency conditions,” but increasing the proportion of
protein in the diet may be one way to attenuate the obesity problem
in a sedentary population and, thereby, to help reduce many of the
obesity-associated comorbidities. Current evidence from experi-
mental and intervention studies suggests that an increase in the
amount of energy provided by protein from the current 15–18% in
most diets to 20–35% is associated with a spontaneous reduction in
total energy intake and a weight loss of relevance for obese and
diabetic subjects (1–4).
Contaldo and Pasinisi note that many individuals already con-
sume high amounts of protein. It is obviously correct that even if a
diet providing only 10% of calories from protein is consumed, it is
still possible to get high amounts of protein if the total amount of
calories consumed is high. However, evidence suggests that it is not
just the absolute amount of protein (grams per day) consumed that is
important, but that a high proportion of energy (% of calories) from
protein is what results in a reduction in total caloric intake (1).
Consequently, a high-protein diet may actually reduce the total
amount of protein eaten, which is a highly relevant issue to be
addressed in light of safety and environmental corollaries. Using
data from the study by Due et al (1), I will provide an example to
support the supposition that a high-protein diet does not necessarily
result in an increase in total protein intake. An average obese indi-
vidual has an energy requirement of 2500 kcal/d, which is provided
by a diet in which 18% of the calories (or 107 g) come from protein.
During the first 3 mo that the subjects consumed a high-protein diet
providing 25% of calories from protein, the fat loss was consistent with
an energy deficit of 700 kcal/d. Because energy requirements due to the
387Am J Clin Nutr 2006;83:387–91. Printed in USA. © 2006 American Society for Nutrition
 at UNIV STUDI NAPO
LI FREDERICO
 II on O
ctober 7, 2013
ajcn.nutrition.org
D
ow
nloaded from
 
 at UNIV STUDI NAPO
LI FREDERICO
 II on O
ctober 7, 2013
ajcn.nutrition.org
D
ow
nloaded from
 
 at UNIV STUDI NAPO
LI FREDERICO
 II on O
ctober 7, 2013
ajcn.nutrition.org
D
ow
nloaded from
 
 at UNIV STUDI NAPO
LI FREDERICO
 II on O
ctober 7, 2013
ajcn.nutrition.org
D
ow
nloaded from
 
 at UNIV STUDI NAPO
LI FREDERICO
 II on O
ctober 7, 2013
ajcn.nutrition.org
D
ow
nloaded from
 
weight loss decreased by 100 kcal/d, the energy intake would have
been1700 kcal/d, of which 25% of energy (or 101 g) was protein.
Most experimental studies suggest that the replacement of some
carbohydrate with protein has a neutral or even positive influence on
inflammation and on risk factors for type 2 diabetes, cardiovascular
disease, and osteoporosis (2–7). The increased protein content of the
diet will normally be based on shellfish, fish, poultry, game, lean
pork and beef, low-fat dairy products, lentils, and beans. However,
our knowledge about the health effects of lean meat and dairy prod-
ucts is still limited. Whereas low-fat dairy products may be benefi-
cial for preventing obesity, the metabolic syndrome, type 2 diabetes
(8), and cardiovascular disease, there is concern that this food group
may play a role in certain cancers. Similarly, processed meat may
increase the risk of type 2 diabetes (9). Even so, on the basis of the
available evidence, I find it difficult to warn individuals who will
benefit from weight loss against replacing some of the less-nutritious
carbohydrate with protein.
However, there are many aspects of high-protein diets that need to
be addressed. We are currently running a large dietary intervention
study (DiOGenes: Diet, Obesity and Genes) to identify the diet that
is most effective for protecting against weight gain and weight regain
in a susceptible population of obese and overweight individuals and
their overweight children (10). This 6–12-mo dietary intervention
will investigate the effect of different dietary components (high and
normal protein contents and high- and low-glycemic-index carbo-
hydrates) on weight-loss maintenance in 350 families in 8 European
research centers. In particular, the safety and tolerability of high-protein
diets in children will be addressed. Such a study would not have been
initiated unless there was a need for more evidence before a higher-
protein diet can be more widely recommended for weight control.
The author had no conflict of interest related to the topic of this letter.
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Reply to F Contaldo and F Pasanisi
Dear Sir:
Contaldo and Pasanisi offer thoughtful insights into the current
global obesity epidemic in regard to food sustainability and the
efficacy and health effects of diets high in protein. We acknowledge
the complexity of the environmental issues related to the depletion of
resources and population growth as well as the social and cultural
implications driving food intake and physical activity.
A goal of our study design (1) was to examine the role of protein
in body weight regulation. The study diets were created to measure
a difference between a moderate-protein diet (15% of energy) and a
high-protein diet (30% of energy). The protein foods used in the diets
were obtained from both animal and vegetable sources to offer va-
riety and appeal to a diverse population; our experience with study
subjects indicates that a diet containing a wide variety of foods is
essential for compliance. Our biggest challenge was to keep the fat
content of the diet at 20% of energy while we increased the protein
content and kept the carbohydrate content constant. To this end we
used fat-free and low-fat dairy foods, egg whites, soy protein, and
lean meats.
We appreciate the concerns of Contaldo and Pasanisi about the
health effects of high-protein diets in regard to calcium and bone
metabolism. We concluded in our article that it is essential to study
the effects of protein-rich diets on renal function and calcium balance
before recommending a high-protein diet for weight loss for the
population at large (1). Perhaps the DiOGenes (Diet, Obesity, and
Genes) trial described in Astrup’s editorial (2) will begin to provide
these answers.
We hereby affirm that none of the authors had a financial, employment, or
promotional conflict of interest relevant to the submission of this letter.
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Assessment of biomarker selection in selenium-
deficiency disease
Dear Sir:
Setting a standard for selenium status evaluation can be vexing.
For example, in a recent article in the Journal, Xia et al (1) concluded
that the use of glutathione peroxidase as an index of selenium status
may not be appropriate. They found that full expression of seleno-
protein P (SeP) requires a greater selenium dietary exposure than
does full expression of plasma glutathione peroxidase activity. This
implies that SeP is a better indicator of selenium nutritional status
than is glutathione peroxidase (1). SeP is the transporter of selenium
in serum (2, 3) and plays important roles in selenium tissue regula-
tion (4–6). However, from the perspective of selenium-related dis-
ease assessments, even changes in SeP concentrations may not be
useful. A low selenium status obtained with the use of glutathione
peroxidase or SeP as indicators in clinical trials did not clearly
predict Keshan disease in selenium-deficienct areas in China (7).
Because SeP is more sensitive to selenium depletion than are other
selenoproteins, it may be too sensitive for use as a standard. Turnover
rates differ among selenoproteins (8, 9), which suggests that the
regulating mechanisms also differ (10); in some tissues, the mech-
anisms of selenium use can be differentially sustained during dietary
selenium depletion (11). Thus, evidence of selenium deficiency ac-
cording to an arbitrary standard does not necessarily lead to a clinical
prediction, even though the activity of a given selenium-containing
enzyme may be reduced. Thus, the evaluation is less robust if it is
based on only one criterion. Practical experience also showed that
the assessment of selenium status should be carried out separately for
different tissues (12). Adoption of SeP as the principal standard for
selenium status evaluation does not adequately focus on the clinical
specificities of different selenium-responsive diseases. In summary,
biomarkers should be selected to match the characteristics of differ-
ent selenium-responsive diseases.
The author had no conflicts of interest.
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Reply to XL Wang
Dear Sir:
Wang raises the issue of which criteria should be used to deter-
mine the selenium requirement and argues that selenoprotein P
might not be the best biomarker for this assessment. Considerable
controversy exists over the selenium intake needed for optimal
health, as indicated by Wang, and a framework for discussion of this
topic is needed.
Many years ago, Keshan disease was shown by Chinese investi-
gators to be a disease that required selenium deficiency for its oc-
currence (1). It was not reported from locations where selenium
intakes were 17 g/d (2). Assertions have been made that other
pathological conditions are related to selenium deficiency, but, so
far, evidence for this remains circumstantial. Thus, available evi-
dence supports the hypothesis that a selenium intake 20 g/d is
required to prevent Keshan disease, the only known selenium-
deficiency disease.
Inferences that much higher selenium intakes protect against car-
diovascular disease and cancer have been drawn from results of
epidemiologic studies. Intervention trials are needed (and some are
underway) to assess these claims and to determine whether these
high-selenium supplements are safe (3). This is an area of research
that is active and important. At present, however, the data available
are largely observational and do not allow firm recommendations for
selenium intake.
Our study addressed the use of selenium biomarkers to assess
selenium nutritional status (4). It is generally accepted that selenium
exerts its biological actions through selenoproteins. Selenoproteins
subserve many biochemical functions and are essential for life. As
Wang points out, a hierarchy of the selenoproteins exists, and some
are maintained better than others as the selenium supply diminishes
(5). It appears that the selenoproteins most essential for life have
higher positions in the hierarchy than do those that are less essential.
Thus, the ideal biomarker by which to assess full expression of all
selenoproteins would be the selenoprotein with the lowest position in
the hierarchy. In studies conducted in rats, liver glutathione perox-
idase appears to occupy the lowest position in the hierarchy and is
therefore the ideal biomarker in that species (6).
Only a few selenoproteins are easily accessible for measurement
in humans, and liver glutathione peroxidase is not among them.
Plasma (or serum) contains 2 selenoproteins—glutathione peroxi-
dase 3 and selenoprotein P—that are readily accessible and easy to
measure, and that is why we compared those 2 selenoproteins. Our
study showed that selenoprotein P was lower in the hierarchy of
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selenoproteins than was plasma glutathione peroxidase. Therefore,
we concluded that selenoprotein P was a better biomarker for whole-
body selenoprotein expression than was plasma glutathione perox-
idase.
Two approaches are being used to determine the selenium nutri-
tional requirement. One approach is disease-related and will require
intervention trials to determine the selenium intake needed to pre-
vent pathological conditions and ensure optimal health. At present,
this approach supports an intake of 20 g selenium/d to protect
against Keshan disease. Intervention trials are being carried out to
determine the effect of higher selenium supplements, and they may
lead to an increase in this recommendation.
The second approach is the use of biomarkers for selenoproteins
to assess the full expression of selenoproteins in the body. This
approach was used in 2000 by the Institute of Medicine to support a
dietary reference intake of 55 g selenium/d, which is based on
plasma glutathione peroxidase activity (7). The same glutathione
peroxidase results were used by a Chinese panel to set a dietary
reference intake of 50 g selenium/d (8). When adequate data on
optimization of selenoprotein P by selenium intake are available, the
current recommendations will likely require an upward revision.
None of the authors had any conflict of interest.
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China
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Do unsaturated fatty acids function as
endogenous antibacterial and antiviral
molecules?
Dear Sir:
The recent study in the Journal by Merchant et al (1) that showed
that higher intakes of -linolenic and cis-linoleic acids (ALA and
LA, respectively) and fish may reduce the risk pneumonia is inter-
esting but not surprising. Previously, I proposed that long-chain
polyunsaturated fatty acids (LCPUFAs), such as -linolenic acid
(GLA), dihomo-GLA (DGLA), arachidonic acid (AA), eicosapen-
taenoic acid (EPA), and docosahexaenoic acid (DHA), may behave
as endogenous antibacterial, antifungal, antiviral, and immuno-
stimulating agents (2).
Kodicek (3) showed that both LA and ALA have a bacteriostatic
effect on gram-positive and gram-negative bacteria. Lacey and Lord
(4) observed that cultures of Staphylococcus aureus seeded onto
human skin were rapidly killed after the skin was covered with ALA
and suggested that ALA had all the attributes of an ideal antibacterial
agent. A variety of bacteria were found to be sensitive to the growth-
inhibitory actions of LA and ALA in vitro (5). Hydrolyzed linseed
oil, which contains 52% ALA and pure LA, killed methicillin-
resistant Staphylococcus aureus (6). Both LA and AA inactivated
animal herpes, influenza, Sendai, and Sindbis viruses within minutes
of contact (7). The oral administration of LA as safflower oil (which
contains 76% LA) produced the remission of mycosis fungoides, a
rare skin disease of viral etiology, in dogs; the remission correlated
with an increase in plasma LA and AA concentrations (8). AA, EPA,
and DHA induced the death of Plasmodium falciparum both in vitro
and in vivo (reviewed in 9). Furthermore, both prostaglandin E1 and
prostaglandin A, which are derived from DGLA, AA, and EPA,
inhibit viral replication and behave as antiviral compounds (10, 11).
These observations suggest that both LCPUFAs and their products
have antibacterial, antifungal, and antiviral actions. Both lympho-
cytes and macrophages contain significant amounts of LCPUFAs
and are capable of releasing them with the appropriate stimulation.
In addition, LCPUFAs stimulate NADPH-dependent superoxide
production by macrophages, neutrophils, and lymphocytes, which is
capable of killing the invading microorganisms (12). In view of these
evidences, it is reasonable to believe that an increased intake of LA,
ALA, EPA, and DHA protects against or reduces the risk of pneu-
monia.
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Recent studies showed that AA, EPA, and DHA could give rise to
antiinflammatory compounds such as lipoxins and resolvins, which
are essential for the limitation and resolution of inflammation (13).
These studies imply that a deficiency of lipoxins and resolvins could
lead to the perpetuation of inflammation and tissue damage.
In light of these facts, it will be interesting to study whether a
subclinical deficiency of LCPUFAs and a decreased formation of
lipoxins and resolvins occurs in subjects who develop various types
of pneumonia and its complications. Because LCPUFAs can inac-
tivate enveloped viruses, including influenza (7), it is probably worth-
while to study the effect of various fatty acids on the bird flu virus and,
if the fatty acids do inactivate the bird flu virus, to study whether in-
creased intake of these fatty acids could reduce the risk of flu.
The author had no conflict of interest.
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